ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibitionPaul G. Kemps, Brianna Empringham, Laura S. Hiemcke‐Jiwa et al.|Blood|2021Cited by 157
Sustained remission after discontinuation of ALK inhibition in ALK-positive histiocytosisPaul G. Kemps, Jean‐François Emile, Jennifer Picarsic et al.|Blood Cancer Journal|2026Cited by 1